Skip to main content

Advertisement

Table 1 Patient demographics and clinical characteristics

From: Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer

Characteristics HypoTRT group
(n = 69)
ConvTRT group
(n = 101)
P
Gender    0.414
 Male 57(82.6%) 88(87.1%)  
 Female 12(17.4%) 13(12.9%)  
Age (yr)    0.698
 Median 59 57  
 Range 31–76 38–83  
Smoking    0.403
 Yes 48(69.6%) 64(63.4%)  
 No 21(30.4%) 37(36.6%)  
Performance status(ECOG)    0.564
 0–1 65(94.2%) 92(91.1%)  
 2 4(5.8%) 9(8.9%)  
TNM stage    0.761
 I-II 10(14.5%) 13(12.9%)  
 III 59(85.5%) 88(87.1%)  
CRT modality    <0.001
 Concurrent CRT 63(91.3%) 50(49.5%)  
 Early radiotherapy 53 34  
 Late radiotherapy 10 16  
 Sequential CRT 6(8.7%) 51(50.5%)  
Cycles of chemotherapy    0.924
 <4 cycles 12(17.4%) 17(16.8%)  
 ≥4 cycles 57(82.6%) 84(83.2%)  
PCI    0.014
 Yes 46(66.7%) 48(47.5%)  
 No 23(33.3%) 53(52.5%)  
  1. Abbreviations: PCI prophylactic cranial irradiation
  2. CRT chemoradiotherapy
  3. ECOG Eastern Cooperative Oncology Group